Drawing for CALEA

USPTO serial 76006246

CALEA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FLETCHER, TRACY L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CALEA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

SCOTT D. WOLDOW

SCOTT D WOLDOW SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of short bowel syndrome, radiation enteritis, malabsorption syndrome, multiple sclerosis, Alzheimer disease, Parkinson disease, primary pulmonary hypertension, cystic fibrosis, stoma, respiratory diseases, cancer diseases, auto immune diseases; preparations for hygiene, namely, all purpose disinfectant, disinfecting handwash, disinfectant for medical instruments, dietetic preparations for medical use and parenteral and enteral feeding, namely, nutritional supplements and nutritional additives, amino acid solutions, carbohydrate solutions for nutritional purposes, fat emulsions for nutritional purposes, food for medically restricted diets, dietary meal replacements for oral or tube feeding; immunosuppressive agents; baby food; medical plasters; wound dressings; surgical dressings; burn dressings; infusion solutions, namely, antibiotic, antiviral, pain management, chemotherapy, hydration, rinsing and blood plasma solutions; medical bags filled with medical infusion solutions, namely, antibiotic, antiviral, pain management, chemotherapy, hydration, rinsing and blood plasma solutionsACTIVE—
010Surgical, medical and veterinary instruments, namely, clips, pumps, syringes, needles, catheters, cannula, plugs, tubes, adapters, connectors, and component parts, therefore; dental instruments, namely, clips, pumps, syringes, needles, catheters, cannula, plugs, tubes, adapters, connectors, and component parts, therefore; medical technical equipment, namely, canes, walkers for invalids, rolators, namely, rolling walkers for invalids; anti-decubitus products, namely, anti-decubitus medical mattresses and cushions; medical storage refrigerators to store compounded infusion bags and other medical products; stoma pouches; incontinence products, namely, incontinence garments, incontinence diapers and incontinence sanitary towels; respiratory home ventilators, respiratory Continuous Positive Airway Pressure machines, oxygen concentrators, respiratory masks, tracheostoma tubes, with the exception of incubators and heat treatment apparatus for newborn and premature babiesACTIVE—
035market research, public relations, advertising and marketing services for others, dissemination of advertising matter, business management consultationACTIVE—
041publishing of books, organizing exhibitions in the nature of conferences, congresses, symposiums, and colloquiums for patients, relatives and aides, to learn how to apply therapy on their own and to care for patients; educational services, namely, conducting seminars for patients, relatives and aides, to learn how to apply therapy on their own and to care for patients, conducting seminars and conferences for medical doctors to inform them about the availability of services for homecare patients; written text editingACTIVE—
042Medical services; medical services, namely, providing drug therapies; health care services; health care services, namely, providing drug therapy management; health care services, namely, provision of medical supplies and medical support services for the administration of drug therapies in the home through a team of pharmacists, healthcare customer service representatives and other healthcare professionals who assist in providing prescribed therapy at home; chemical research; scientific research in the fields of enteral and parenteral nutrition and infusion technology; chemical analysisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 27, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 27, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 15, 2004EX2GSOU EXTENSION 2 GRANTED—
Oct 29, 2004EXT2SOU EXTENSION 2 FILED—
Oct 29, 2004MAILPAPER RECEIVED—
May 24, 2004EX1GSOU EXTENSION 1 GRANTED—
May 20, 2004CFITCASE FILE IN TICRS—
May 6, 2004EXT1SOU EXTENSION 1 FILED—
May 6, 2004MAILPAPER RECEIVED—
Nov 11, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 23, 2003ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 25, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2003NPUBNOTICE OF PUBLICATION—
Dec 11, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 9, 2002CNEAEXAMINERS AMENDMENT MAILED—
Dec 8, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 21, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 28, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 21, 2002CNEAEXAMINERS AMENDMENT MAILED—
Jul 10, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2002MAILPAPER RECEIVED—
Jan 4, 2002CNSLLETTER OF SUSPENSION MAILED—
Sep 5, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 11, 2001CNSLLETTER OF SUSPENSION MAILED—
Feb 27, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 28, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 24, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance